ACN vs MRSH vs EXPO Stock Comparison

Accenture, Marsh & Mclennan Companies and Exponent Prices as of Nov 13, 2026 Peers: Industry group
ACN Accenture plc
$250.43 +16.5% 1M +1.2% 1Y
Market cap
$151.55B
P/E
18.1x
Revenue (TTM)
$74.18B
Div. yield
0.03%
Consulting Industrials
7 wins
EXPO Exponent Inc
$87.31 +22.8% 1M +24.9% 1Y
Market cap
$4.24B
P/E
36.9x
Revenue (TTM)
$659.07M
Div. yield
–
Consulting Industrials
3 wins

Head to Head

12 decided of 12

Accenture leads on 7 of the 12 questions below (Accenture 7, Exponent 3, Marsh & Mclennan Companies 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionACNMRSHEXPOLeader
Larger companyMarket capitalisation $151.55B $100.06B $4.24B ACN
Cheaper on earningsLower P/E, profitable companies only 18.1x 24.8x 36.9x ACN
Cheaper on forward earningsLower price / next fiscal year consensus EPS 16.3x 20.3x 38.6x ACN
Faster revenue growthRevenue growth, trailing twelve months +6.5% +7.6% +15.4% EXPO
More profitableNet margin, trailing twelve months 11.3% 14.2% 17.4% EXPO
Better return on capitalReturn on invested capital 21.1% 13.1% — ACN
Less leveragedLower net debt / EBITDA -0.2x 2.7x — ACN
Higher dividend yieldTrailing dividend yield 0.03% 0.02% 0.00% ACN
Better 1-year returnPrice return, last 12 months +1.2% +13.0% +24.9% EXPO
Better 5-year returnAnnualised price return, 5 years -7.6%/yr +4.5%/yr -6.9%/yr MRSH
Less volatileAnnualised volatility, 1 year 50.7% 26.1% 33.2% MRSH
Higher overall scoreMean of the five percentile scores vs peers 67/100 33/100 56/100 ACN

Percentile Scorecard

ACNMRSHEXPO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisACNMRSHEXPO
Valuation 50 #59 of 117 10 #109 of 121 24 #89 of 117
Growth 57 #44 of 102 17 #98 of 118 73 #28 of 102
Profitability 87 #14 of 97 69 #38 of 119 92 #9 of 97
Financial Health 76 #32 of 128 18 #97 of 118 72 #36 of 128
Shareholder Returns 64 #28 of 76 51 #55 of 111 19 #62 of 76
Overall 67 33 56
  • ACN ranked among 132 companies in Business Services
  • MRSH ranked among 127 companies in Insurance
  • EXPO ranked among 132 companies in Business Services

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodACNMRSHEXPOSPY
1 month +16.5%+16.4%+22.8% -2.0%
3 months +41.6%+10.6%+30.1% -2.8%
6 months +48.3%+29.0%+62.3% +2.0%
Year to date -6.7%+12.0%+25.7% +10.6%
1 year +1.2%+13.0%+24.9% +12.2%
3 years -21.9%+4.9%+11.3% +68.1%
3 years, per year -7.9%+1.6%+3.6% +18.9%
5 years -32.5%+24.6%-29.9% +61.4%
5 years, per year -7.6%+4.5%-6.9% +10.1%
10 years +110.1%+206.5%+180.9% +248.5%
10 years, per year +7.7%+11.9%+10.9% +13.3%

Risk

MeasureACNMRSHEXPOSPY
Volatility, 1Y 50.7%26.1%33.2% 13.6%
Downside volatility, 1Y 51.9%24.9%29.5% 13.9%
Beta vs S&P 500, 1Y -0.03-0.310.33 1.00
Return / volatility, 1Y 0.020.500.75 0.90
Max drawdown, 5Y -70.0%-35.6%-57.2% -25.4%
From 52-week high -13.2%-1.3%-0.1% -3.2%
52-week high $288.54$210.46$87.43 $779.14
52-week low $124.44$157.32$53.67 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleACNMRSHEXPO
P/E now vs peer median 18.3xmedian 22.8x 24.5xmedian 11.0x 36.6xmedian 22.8x
P/S now vs peer median 2.3xmedian 0.9x 3.5xmedian 1.5x 6.3xmedian 0.9x
EV/EBITDA now vs peer median 12.0xmedian 10.6x 16.8xmedian 7.5x 26.8xmedian 10.6x
P/FCF now vs peer median 14.4xmedian 14.0x 23.8xmedian 8.1x 26.0xmedian 14.0x
P/B now vs peer median 5.1xmedian 2.1x 6.6xmedian 1.5x 13.5xmedian 2.1x
PEG now vs peer median 2.30median 0.88 3.66median 0.53 5.85median 0.88

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsACNMRSHEXPO
Revenue $74.18B $28.46B $659.07M
Gross profit $23.78B – –
Operating income $11.41B $6.09B $140.42M
Net income $8.37B $4.12B $114.67M
Free cash flow $11.62B $4.15B $159.42M
EPS (diluted) $13.55 $8.44 $2.37
Cash & equivalents $12.83B $1.84B $114.69M
Total debt $10.11B $20.53B –
Shares (diluted) 617.50M 479.00M 48.42M
Enterprise value $109.48B $92.22B $3.73B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricACNMRSHEXPO
P/E 18.3x 24.5x 36.6x
P/FCF 14.4x 23.8x 26.0x
P/Operating cash flow 13.5x 22.1x 27.9x
P/S 2.3x 3.5x 6.3x
P/B 5.1x 6.6x 13.5x
P/Tangible book 5.6x 9.5x 13.5x
EV/EBITDA 12.0x 16.8x 26.8x
EV/EBIT 14.4x 19.3x 28.8x
EV/Revenue 2.2x 4.1x 6.1x
EV/FCF 14.2x 28.3x 25.3x
EV/Operating cash flow 13.3x 26.2x 27.1x
PEG (3Y EPS CAGR) 2.30 3.66 5.85

Growth

14 metrics
MetricACNMRSHEXPO
Revenue growth (1Y) 6.5% 7.6% 15.4%
Revenue CAGR (3Y) 5.0% 8.6% 6.8%
Gross profit growth (1Y) 6.9% – –
Gross profit CAGR (3Y) 4.7% – –
Operating income growth (1Y) 11.5% -1.0% 19.1%
Operating income CAGR (3Y) 9.0% 7.8% 6.9%
Net income growth (1Y) 9.0% -1.9% 9.4%
Net income CAGR (3Y) 6.8% 5.5% 4.0%
EPS growth (1Y) 11.6% 1.0% 15.6%
EPS CAGR (3Y) 8.0% 6.7% 6.3%
Operating cash flow growth (1Y) 7.7% -12.1% 12.5%
Operating cash flow CAGR (3Y) 9.1% 4.0% 15.5%
Free cash flow growth (1Y) 6.9% -13.9% 29.7%
Free cash flow CAGR (3Y) 8.9% 5.1% 24.7%

Profitability

14 metrics
MetricACNMRSHEXPO
Gross margin 32.0% – –
EBITDA margin 18.6% 24.6% 22.9%
Operating margin 15.4% 21.4% 21.3%
Pretax margin 15.3% 18.9% 24.3%
Net margin 11.3% 14.2% 17.4%
FCF margin 15.7% 14.6% 24.2%
Operating cash flow margin 16.7% 15.7% 22.6%
Return on equity 25.9% 27.2% 38.4%
Return on assets 12.0% 6.9% 17.0%
Return on invested capital 21.1% 13.1% –
Return on capital employed 23.3% 16.2% 28.6%
Asset turnover 1.0x 0.5x 1.0x
Cash conversion (OCF / net income) 1.5x 1.1x 1.3x
Stock comp / revenue 2.8% 1.5% 4.2%

Financial Health

11 metrics
MetricACNMRSHEXPO
Debt / assets 13.7% 34.3% –
Debt / equity 0.3x 1.4x –
Net debt / EBITDA -0.2x 2.7x –
Debt / FCF 0.9x 4.9x –
Liabilities / assets 55.5% 75.1% 55.7%
Equity / assets 44.5% 24.9% 44.3%
Interest coverage 37.6x 6.3x –
Current ratio 1.4x 1.1x 1.9x
Quick ratio 1.4x 0.5x 1.8x
Cash ratio 0.6x 0.1x 0.6x
Altman Z-score 4.61 2.85 9.78

Shareholder Returns

7 metrics
MetricACNMRSHEXPO
Dividend yield 2.6% 1.8% 1.4%
Net buyback yield 3.7% 2.9% -0.7%
Shareholder yield 6.3% 4.7% 0.8%
Payout ratio (earnings) 47.7% 43.6% –
Payout ratio (FCF) 34.3% 43.3% –
Dividend growth (1Y) 7.8% 8.4% –
Dividend CAGR (3Y) 12.1% 13.1% –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusACNMRSHEXPO
Forward P/E 16.3xFY2027 20.3xFY2026 38.6xFY2026
EPS, next fiscal year $15.40FY2027 $10.22FY2026 $2.26FY2026
EPS growth, next FY +10.2%FY2027 +4.8%FY2026 +9.2%FY2026
EPS growth, the year after -2.2% +15.3% +13.7%
Revenue, next fiscal year $72.38BFY2027 $30.28BFY2026 $606.16MFY2026
Revenue growth, next FY -2.4%FY2027 +12.2%FY2026 +12.9%FY2026
Revenue growth, the year after +18.1% +6.4% +0.3%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersACNMRSHEXPO
Held by institutions 72.9% 93.9% 92.3%
Institutions holding 1,901 1,501 338
Change in shares held, QoQ -1.6% +2.8% -1.1%
Institutions buying 957 626 155
Institutions selling 779 655 146
Buyers to sellers 1.23 0.96 1.06

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ACNMRSHEXPO
ACN 1.00 0.48 0.54
MRSH 0.48 1.00 0.41
EXPO 0.54 0.41 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ACN, MRSH and EXPO?

Accenture (ACN) is the largest by market capitalisation: Accenture (ACN) $151.55B, Marsh & Mclennan Companies (MRSH) $100.06B, Exponent (EXPO) $4.24B.

Which stock is cheaper, ACN, MRSH and EXPO?

Accenture (ACN) trades on the lowest price-to-earnings ratio (Accenture (ACN) 18.1x, Marsh & Mclennan Companies (MRSH) 24.8x, Exponent (EXPO) 36.9x). On next year's consensus earnings, Accenture (ACN) is cheapest (Accenture (ACN) 16.3x, Marsh & Mclennan Companies (MRSH) 20.3x, Exponent (EXPO) 38.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Exponent (EXPO) grew revenue fastest over the trailing twelve months: Accenture (ACN) +6.5%, Marsh & Mclennan Companies (MRSH) +7.6%, Exponent (EXPO) +15.4%.

Which company is more profitable?

Exponent (EXPO) has the highest net margin (Accenture (ACN) 11.3%, Marsh & Mclennan Companies (MRSH) 14.2%, Exponent (EXPO) 17.4%). On return on invested capital, Accenture (ACN) leads (Accenture (ACN) 21.1%, Marsh & Mclennan Companies (MRSH) 13.1%).

Which stock has performed better?

Over the past year Exponent (EXPO) returned the most: Accenture (ACN) +1.2%, Marsh & Mclennan Companies (MRSH) +13.0%, Exponent (EXPO) +24.9%. Over five years, Marsh & Mclennan Companies (MRSH) compounded fastest (Accenture (ACN) -7.6%/yr, Marsh & Mclennan Companies (MRSH) +4.5%/yr, Exponent (EXPO) -6.9%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Accenture (ACN) has the highest dividend yield: Accenture (ACN) 0.03%, Marsh & Mclennan Companies (MRSH) 0.02%, Exponent (EXPO) 0.00%. Exponent (EXPO) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Marsh & Mclennan Companies (MRSH) has been the steadiest (Accenture (ACN) 50.7%, Marsh & Mclennan Companies (MRSH) 26.1%, Exponent (EXPO) 33.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ACN, MRSH and EXPO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Accenture (ACN) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.